These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3471725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The adverse effects of fluoroquinolones.
    Smith CR.
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW.
    Drugs; 1987 Jun; 34 Suppl 1():91-4. PubMed ID: 3481333
    [Abstract] [Full Text] [Related]

  • 5. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.
    Mavromanolakis E, Maraki S, Cranidis A, Tselentis Y, Kontoyiannis DP, Samonis G.
    Scand J Infect Dis; 2001 Jun; 33(6):477-8. PubMed ID: 11450873
    [Abstract] [Full Text] [Related]

  • 6. Ofloxacin-induced psychosis.
    Zaudig M, von Bose M.
    Br J Psychiatry; 1987 Oct; 151():563-4. PubMed ID: 3482162
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
    Wilton LV, Pearce GL, Mann RD.
    Br J Clin Pharmacol; 1996 Apr; 41(4):277-84. PubMed ID: 8730972
    [Abstract] [Full Text] [Related]

  • 8. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
    Clark DW, Layton D, Wilton LV, Pearce GL, Shakir SA.
    Drug Saf; 2001 Apr; 24(15):1143-54. PubMed ID: 11772147
    [Abstract] [Full Text] [Related]

  • 9. Quinolones-induced acral erythema.
    Bonnetblanc JM, Bernard P.
    Therapie; 1996 Apr; 51(5):601-2. PubMed ID: 9138405
    [No Abstract] [Full Text] [Related]

  • 10. Ofloxacin in lower respiratory tract infections.
    Hänninen P.
    Drugs; 1987 Apr; 34 Suppl 1():179-80. PubMed ID: 3481320
    [No Abstract] [Full Text] [Related]

  • 11. [Psychotic reactions during administration of quinolones].
    Salm EF, Egberts AC, Maartense E, Hart W, Stricker BH.
    Ned Tijdschr Geneeskd; 1994 May 21; 138(21):1080-2. PubMed ID: 8202181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of quinolones in respiratory tract infections.
    Maesen FP, Davies BI, Geraedts WH, Baur C.
    Drugs; 1987 May 21; 34 Suppl 1():74-9. PubMed ID: 3325259
    [Abstract] [Full Text] [Related]

  • 14. Ofloxacin in cystic fibrosis.
    Meyer H.
    Drugs; 1987 May 21; 34 Suppl 1():177-9. PubMed ID: 3481319
    [No Abstract] [Full Text] [Related]

  • 15. Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Report on 2 cases.
    Baran R, Brun P.
    Dermatologica; 1986 May 21; 173(4):185-8. PubMed ID: 2945743
    [Abstract] [Full Text] [Related]

  • 16. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    Infection; 1986 May 21; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ofloxacin in elderly patients.
    Bruch K, Blomer R.
    Int J Clin Pharmacol Res; 1987 May 21; 7(3):195-8. PubMed ID: 3298084
    [Abstract] [Full Text] [Related]

  • 18. Polymorphonuclear leucocyte chemotaxis little affected by three quinolones in vitro.
    Lombard JY, Descotes J, Evreux JC.
    J Antimicrob Chemother; 1987 Oct 21; 20(4):614-5. PubMed ID: 3479421
    [No Abstract] [Full Text] [Related]

  • 19. Use of the new quinolones during pregnancy.
    Koren G.
    Can Fam Physician; 1996 Jun 21; 42():1097-9. PubMed ID: 8704483
    [No Abstract] [Full Text] [Related]

  • 20. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
    Fujita H, Matsuo I.
    Photodermatol Photoimmunol Photomed; 1994 Oct 21; 10(5):202-5. PubMed ID: 7880759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.